Clinical trial
A Study in Prevention of Re-emergence of Depression Symptoms
NCT01299272
Study timeline
Study start (unknown)2011-05-01Date precision: month
Registry last updated2018-04-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorderunresolved
Interventions
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
New YorkNew York, United States1BostonMassachusetts, United States1PhiladelphiaPennsylvania, United States1AtlantaGeorgia, United States1SeoulSouth Korea1MadridSpain1CincinnatiOhio, United States1Oklahoma CityOklahoma, United States1AustinTexas, United States1RochesterNew York, United States1Las VegasNevada, United States1MoscowRussia1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01299272 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.